Extent of Low-density Lipoprotein Cholesterol Reduction and All-cause and Cardiovascular Mortality Benefit: A Systematic Review and Meta-analysis

Lipid-modifying agents steadily lower low-density lipoprotein cholesterol (LDL-C) levels with the aim of reducing mortality. A systematic review and meta-analysis were conducted to determine whether all-cause or cardiovascular (CV) mortality effect size for lipid-lowering therapy varied according to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ennezat, Pierre Vladimir, Guerbaai, Raphaëlle-Ashley, Maréchaux, Sylvestre, Le Jemtel, Thierry H., François, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812424/
https://www.ncbi.nlm.nih.gov/pubmed/36027598
http://dx.doi.org/10.1097/FJC.0000000000001345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812424/
https://www.ncbi.nlm.nih.gov/pubmed/36027598
http://dx.doi.org/10.1097/FJC.0000000000001345

Ejemplares similares